Policy
Drug price hikes in Germany could push US costs higher, study says
BioPharma Dive · By Kristin Jensen ·
The Brief
- A study says drug price hikes in Germany could push US drug costs higher.
- The findings come amid escalating tensions between the US and Germany over drug prices.
- Several large pharmaceutical companies are scaling back investments in Germany in response.
Why it matters
Drug pricing decisions in one country can spill over into costs in another, affecting how medicines are funded and how much research and development companies undertake.
Who’s affected
- anyone with a stake in drug pricing policy
- patients and payers in the US
- health economists and policy researchers
- #drug prices
- #pharmaceuticals
- #health policy
- #healthcare costs
- #germany
The report comes amid escalating tensions between the U.S. and Germany over drug prices, with several large pharmaceutical companies responding by scaling back investments in the country.
Timeline
BioPharma Dive reports study finding that German drug price hikes could raise US costs
BioPharma Dive - Latest News
Drug price hikes in Germany could push US costs higher, study says